The Mexico clinical trials market was valued at USD 379.51 Million in 2025, driven by rising biotechnology investments and strengthened regulatory support with enhanced infrastructure initiatives in the region. The market is anticipated to grow at a CAGR of 4.10% during the forecast period of 2026-2035, with the values likely to reach USD 567.19 Million by 2035. The market growth is driven by rising clinical trials in Mexico as they are relatively more affordable than in the United States or Europe, offering a cost advantage without compromising quality.
Base Year
Historical Period
Forecast Period
In December 2024, Mexico's Cofepris approved Leqembi® (Lecanemab) for early Alzheimer's treatment. based on the phase 3 Clarity AD study. Such approvals are expected to drive growth in the clinical trials market.
The Mexico clinical trials market is witnessing an increased adoption of decentralized trials and enhanced focus on neurodegenerative diseases. These trends are expected to enhance the market demand in the coming years.
Key players in the market such as global pharmaceutical companies, CROs, and regulatory bodies are contributing to the expansion of clinical trial activities, particularly in oncology, neurology, and rare diseases.
Compound Annual Growth Rate
4.1%
Value in USD Million
2026-2035
*this image is indicative*
Clinical trials are controlled research studies conducted to evaluate the safety, efficacy, and optimal use before regulatory approval and widespread clinical application. According to Regulatory Focus factsheet, Mexico registered around 5,000 clinical studies by April 2024. The clinical trials market in Mexico is growing steadily, driven by a skilled workforce, cost efficiency, diverse patient population, and supportive regulatory environment, making it an attractive location for global pharmaceutical research.
Adoption of Digital Platforms to Promote Ease in Regulatory Approvals
A key growth driver in the Mexico clinical trials market is the recent digital transformation of regulatory processes. In February 2023, the Federal Commission for Protection against Health Risks (Cofepris) launched the Digital Platform for Research and Clinical Trials (Digipris), which enables researchers to submit and manage clinical trial protocols entirely online. By eliminating the need for in-person appointments and physical paperwork, Digipris significantly accelerates approval timelines, enhances transparency, and improves regulatory efficiency, making Mexico a more attractive destination for both domestic and international clinical research sponsors.
Some of the notable trends include the ease in regulations to promote clinical trial activities.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
Market Breakup by Service Type
Market Breakup by Therapeutic Areas
Market Breakup by Type of Pharmaceutical Product
Market Breakup by Study Design
Market Breakup by Delivery Model
Market Breakup by End User
Laboratory Services Projected to Hold Significant Share for Segmentation by Service Type
By service type, the market is categorized into laboratory services, bioanalytical testing services, decentralized clinical trial services, patient recruitment, site identification, analytical testing services, clinical trial supply and logistic services, protocol designing, clinical trial data management services, medical device testing services, and other services. Laboratory services are expected to dominate, owing to their essential function in clinical diagnostics and continuous demand for precise and standardized testing procedures. For instance, in November 2024, UL Solutions Inc., a global leader in applied safety science, expanded its laboratory capacity and capabilities in Mexico to support the rising demand for product safety and performance testing. This move highlights the increasing focus on laboratory and analytical services within Mexico’s clinical trials market, reflecting growing investment in local infrastructure to meet the needs of pharmaceutical and medical device manufacturers across Latin America.
Oncology to Lead the Market Share by Therapeutic Area
According to therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases, women's health, and others. According to the Global Cancer Observatory (2022), Mexico is expected to have over 500,000 five-year prevalent cancer cases, highlighting a significant disease burden. Hence, oncology is projected to lead due to increasing cancer prevalence, rising awareness, and significant investment in research and development of targeted therapies and immuno-oncology treatments.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
IQVIA is a global leader in advanced analytics and clinical research. In Mexico, the company plays a significant role in the clinical trials market by offering innovative solutions such as Clinical Data Analytics Solutions (CDAS), orchestrated clinical trials, and tech-enabled services. These platforms use artificial intelligence and machine learning to streamline trial oversight, accelerate data processing, and enhance decision-making. IQVIA’s presence supports Mexico’s growing reputation as a strategic hub for efficient, technology-driven clinical research and pharmaceutical development.
Althian is a leading provider of specialized clinical research services. The company plays a vital role in the market by offering comprehensive solutions such as clinical trial supplies management, biomarker and laboratory services, medical writing, and risk management. Known for its regulatory compliance and operational efficiency, Althian supports global firms in conducting successful trials across diverse therapeutic areas.
Parexel is a global leader in providing comprehensive clinical trial and regulatory services. The company offers solutions across a wide range of therapeutic areas, including oncology, infectious diseases, as well as cell and gene therapies. In Mexico, Parexel plays a crucial role in advancing clinical trials by leveraging its global expertise and local regulatory knowledge to optimize drug development, streamline trials, and ensure efficient market entry. The company’s services are essential for multinational pharmaceutical and biotech companies conducting research in the region.
PPD is a part of Thermo Fisher Scientific, established in 1985 and headquartered in Wilmington, North Carolina. PPD, its clinical research branch plays a significant role in the clinical trials market. Known for digital transformation in clinical development, Thermo Fisher is recognized for its decentralized trials capabilities, diverse patient engagement, and advanced pharmacovigilance solutions. With a focus on improving patient access and trial efficiency, it helps accelerate the development of new medicines, fostering innovation and addressing key challenges like patient diversity and socioeconomic barriers in clinical trials.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Cohortias, Fractals Clinical Research, MCR (Marketing & Clinical Research), Medpace Holdings Inc., SGS de Mexico, and Syneos Health, among others.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Phase |
|
| Breakup by Service Type |
|
| Breakup by Therapeutic Areas |
|
| Breakup by Pharmaceutical Product |
|
| Breakup by Study Design |
|
| Breakup by Delivery Model |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share